FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2335836427> ?p ?o ?g. }

• W2335836427 endingPage "260" @default.
• W2335836427 startingPage "246" @default.
• W2335836427 abstract "Context: Three-dimensional tumor spheroid cultures are a better representative of in vivo solid tumors than monolayer cultures and should be used for testing potential nanotherapeutics in vitro.Objective: To develop techniques to test the disposition and efficacy of nanocarrier formulations in spheroids in a cost-effective manner amenable to high-throughput testing.Methods: Spheroids were obtained using a modified liquid overlay technique in a 96-well plate. Several nanocarrier formulations were prepared and tested in the spheroid model. The disposition of the formulations in the spheroids was determined by confocal microscopy while the effect of the drug-loaded formulations was assessed in terms of the cell viability, loss of membrane integrity, induction of caspases and inhibition of growth of the spheroids.Results: The surface charge of the formulations influenced the accumulation of the nanocarrier and drug in the spheroid, with the cationic formulation accumulating to the greatest extent. Also, the smallest particle size formulation, micelles, penetrated to the greatest extent in the spheroid. The iRGD tumor-penetrating peptide co-administered with unmodified liposomes exhibited both high accumulation and penetration. The effect studies revealed that the formulations that penetrated or accumulated to the highest extent in the spheroid exhibited better antitumor activity compared to the other formulations.Conclusion: The 96-well plate format spheroid model developed in the study can be used toward the rational selection of nanocarrier therapeutics prior to their testing in in vivo models." @default.
• W2335836427 created "2016-06-24" @default.
• W2335836427 creator A5000062245 @default.
• W2335836427 creator A5076543465 @default.
• W2335836427 creator A5090380505 @default.
• W2335836427 date "2016-01-18" @default.
• W2335836427 modified "2023-10-10" @default.
• W2335836427 title "Development of an <i>in vitro</i> tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics" @default.
• W2335836427 cites W1871642698 @default.
• W2335836427 cites W1963722513 @default.
• W2335836427 cites W1964553162 @default.
• W2335836427 cites W1967217835 @default.
• W2335836427 cites W1967261468 @default.
• W2335836427 cites W1976550785 @default.
• W2335836427 cites W1977116179 @default.
• W2335836427 cites W1980324695 @default.
• W2335836427 cites W1983519686 @default.
• W2335836427 cites W1987564805 @default.
• W2335836427 cites W1989072027 @default.
• W2335836427 cites W1998679085 @default.
• W2335836427 cites W2003335129 @default.
• W2335836427 cites W2004934153 @default.
• W2335836427 cites W2009183786 @default.
• W2335836427 cites W2010251891 @default.
• W2335836427 cites W2010509371 @default.
• W2335836427 cites W2023062664 @default.
• W2335836427 cites W2024616335 @default.
• W2335836427 cites W2025424860 @default.
• W2335836427 cites W2027154963 @default.
• W2335836427 cites W2030680926 @default.
• W2335836427 cites W2033813787 @default.
• W2335836427 cites W2034198373 @default.
• W2335836427 cites W2034618316 @default.
• W2335836427 cites W2044803596 @default.
• W2335836427 cites W2045416947 @default.
• W2335836427 cites W2057642134 @default.
• W2335836427 cites W2077800215 @default.
• W2335836427 cites W2080270710 @default.
• W2335836427 cites W2081787581 @default.
• W2335836427 cites W2090075420 @default.
• W2335836427 cites W2094454542 @default.
• W2335836427 cites W2096391616 @default.
• W2335836427 cites W2105017561 @default.
• W2335836427 cites W2123647020 @default.
• W2335836427 cites W2129213113 @default.
• W2335836427 cites W2148512402 @default.
• W2335836427 cites W2167407535 @default.
• W2335836427 cites W2169187623 @default.
• W2335836427 cites W4252941190 @default.
• W2335836427 doi "https://doi.org/10.3109/08982104.2015.1105820" @default.
• W2335836427 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26780923" @default.
• W2335836427 hasPublicationYear "2016" @default.
• W2335836427 type Work @default.
• W2335836427 sameAs 2335836427 @default.
• W2335836427 citedByCount "24" @default.
• W2335836427 countsByYear W23358364272017 @default.
• W2335836427 countsByYear W23358364272018 @default.
• W2335836427 countsByYear W23358364272019 @default.
• W2335836427 countsByYear W23358364272020 @default.
• W2335836427 countsByYear W23358364272021 @default.
• W2335836427 countsByYear W23358364272022 @default.
• W2335836427 countsByYear W23358364272023 @default.
• W2335836427 crossrefType "journal-article" @default.
• W2335836427 hasAuthorship W2335836427A5000062245 @default.
• W2335836427 hasAuthorship W2335836427A5076543465 @default.
• W2335836427 hasAuthorship W2335836427A5090380505 @default.
• W2335836427 hasBestOaLocation W23358364272 @default.
• W2335836427 hasConcept C109316439 @default.
• W2335836427 hasConcept C121608353 @default.
• W2335836427 hasConcept C12554922 @default.
• W2335836427 hasConcept C150903083 @default.
• W2335836427 hasConcept C151730666 @default.
• W2335836427 hasConcept C171250308 @default.
• W2335836427 hasConcept C175369904 @default.
• W2335836427 hasConcept C18150654 @default.
• W2335836427 hasConcept C185154212 @default.
• W2335836427 hasConcept C185592680 @default.
• W2335836427 hasConcept C192562407 @default.
• W2335836427 hasConcept C202751555 @default.
• W2335836427 hasConcept C207001950 @default.
• W2335836427 hasConcept C2777292972 @default.
• W2335836427 hasConcept C2779343474 @default.
• W2335836427 hasConcept C2779820397 @default.
• W2335836427 hasConcept C54355233 @default.
• W2335836427 hasConcept C55493867 @default.
• W2335836427 hasConcept C86803240 @default.
• W2335836427 hasConceptScore W2335836427C109316439 @default.
• W2335836427 hasConceptScore W2335836427C121608353 @default.
• W2335836427 hasConceptScore W2335836427C12554922 @default.
• W2335836427 hasConceptScore W2335836427C150903083 @default.
• W2335836427 hasConceptScore W2335836427C151730666 @default.
• W2335836427 hasConceptScore W2335836427C171250308 @default.
• W2335836427 hasConceptScore W2335836427C175369904 @default.
• W2335836427 hasConceptScore W2335836427C18150654 @default.
• W2335836427 hasConceptScore W2335836427C185154212 @default.
• W2335836427 hasConceptScore W2335836427C185592680 @default.
• W2335836427 hasConceptScore W2335836427C192562407 @default.
• W2335836427 hasConceptScore W2335836427C202751555 @default.

• next